Tom Martin, M.A., MBA

home / authors / tom-martin-m-a-mba

Tom Martin, M.A., MBA, is vice president, client relations, DRG Claims Management

Articles

CMS’s RADV Strategy Will Reverberate Throughout Health Plan Operations

CMS’s RADV Strategy Will Reverberate Throughout Health Plan Operations

Eric Levine, M.P.H.;Tom Martin, M.A., MBA
June 30th 2025

To prepare for CMS’ new risk adjustment data validation (RADV) strategy, Medicare Advantage plans must take a coordinated, organization-wide approach.

Read More

What a Nonpayment Integrity SME Needs to Know About Payment Integrity

What a Nonpayment Integrity SME Needs to Know About Payment Integrity

Tom Martin, M.A., MBA
June 4th 2025

Read More

AI written on brain floating over circuitry imagery | Image credit : ©fanjianhua stock.adobe.com

Embracing AI Wisely: A Health Plan Leader’s Guide to Benefits, Risks, and Readiness

Tom Martin, M.A., MBA;Eric Levine, M.P.H.;Viju Shamana
May 7th 2025

The authors provide a detailed framework for assessing the adoption of artificial intelligence.

Read More

Latest Updated Articles

Gaps in Diabetes Patient Education and Rising Healthcare Costs
Published: February 25th 2025 | Updated: February 28th 2025
Gaps in Diabetes Patient Education and Rising Healthcare Costs
black and white image of solders in jungle setting | ©daniel stock.adobe.com
Published: February 16th 2025 | Updated: February 19th 2025
Many Aging Vietnam War Vets Are Still Battling PTSD, Along With Chronic Illnesses, That Combat Exposure May Make More Likely, New Research Finds
food in heart shape with a stethoscope | image credit: ©udra11
Published: February 5th 2025 | Updated: February 7th 2025
A Key Ingredient to ‘Food is Medicine’: Standardization
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Published: January 30th 2025 | Updated: January 31st 2025
Evernorth Drives Cigna's Strong Revenue Growth and Focuses on Biosimilars and Drug Affordability
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
Published: June 27th 2025 | Updated: June 30th 2025
Navigating Healthcare's Future: An Insider's View on Network Strategy, Employer Innovation and Policy Challenges
FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults
Published: June 20th 2025 | Updated: June 30th 2025
FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults
© 2025 MJH Life Sciences

All rights reserved.